Epithra 100 mg Epirubicin Injection

Epirubicin Injection Hospital, Wholesale and Named Patient Supply

Product Category

Epirubicin injection refers to an anthracycline-based oncolytic cytotoxic agent that belongs to Breast Cancer Drugs and agents against breast cancer to be administered in hospitals.

Epirubicin hydrochloride as an injected drug is available in institutional oncology and control chemotherapy procurement channels.

Overview of Institutional Buyers and Wholesale Buyers

Epirubicin is a widely procured drug that is used in structured chemotherapy programs by oncology hospitals, cancer treatment centers, government institutions, and International pharmaceutical wholesalers by injection in the market.

Epirubicin hydrochloride for injection source is usually procured by centralized procurement tenders and through controlled hospital pharmacies.

epirubicin hydrochloride for injection is a part of the Breast Cancer Drugs portfolios that is available in the institutional oncology formulary and epirubicin uses within a qualified medical approved scheme of treatment.

In Morocco, Malaysia, Nigeria, Philippines, Nepal, Kuwait, Georgia, Madagascar, Myanmar and Armenia, institutional purchasers participate repeatedly in bulk purchase in accordance with national cancer initiatives and health supply networks.

This product is distributed exclusively to the hospital and institutional segment as the distribution would be following the international standards of distribution of pharmaceuticals.

Epirubicin injection and epirubicin hydrochloride injection are not available to retail pharmacy and individual consumer sales. Only licensed institutions and authorized procurement entities are allowed to receive distribution.

Regulatory/Compliance Factors

The epirubicin hydrochloride for injection are shipped in line with the international pharmaceutical export policies as well as the domestic import policies. Regulatory documentation can be:

• Certificate of Pharmaceutical Product (CPP).
• Bay manufacturing documents.
• Certificate of Analysis (CoA)
• Export documents which are compliant with GDP.
• Cold chain verification (where necessary)

Institutional purchasers are recommended to be in harmony with local oncology drug importation regulations, pharmacovigilance reporting policies, especially on side effects of epirubicin noted during clinical supervision systems.

Packaging & Presentation

epirubicin hydrochloride for injection is normally provided in injectable dosages using in-house grade vials that are presented in the form of sterile vials that could be used in controlled oncology preparation units.

Wholesale and Institutional Supply Abilities

Oddway international is a supplier of epirubicin injection on wholesale basis via organised B2B pharmaceutical export delivery. Capabilities include:

• Oncology products portfolios consolidated such as Breast Cancer Drugs.
• Sponsorship of global pharmaceutical distributors.

We also ease procurement in Morocco, Malaysia, Nigeria, Philippines, Nepal, Kuwait, Georgia, Madagascar, Myanmar and Armenia, which are subject to regulatory clearance and import permission.

Known as Patient and Case-Based Access.

In jurisdictions where epirubicin hydrochloride injection is not approved commercially, a supply can be realized within Named Patient Programs (NPP) and case based supply, as required by local health authority requirements.

Such supply is subject to:

• Effective physician order.
• Institutional authorization
• Survey audit of regulatory documentation.
• Permission to administer importation (where necessary)

This will guarantee ethical and valid access routes to important oncology medications.

Global Distribution, Logistics

Oddway international runs its business networks based on global distribution channels that are aligned with the GDP, facilitating the security in exporting epirubicin injection to the controlled healthcare systems across the world.

Logistics support includes:

• Temperature-monitored shipping
• Air freight coordination
• Customs clearance form.
• Pharmacovigilance and batch traceability assistance.
• Long distance transportation secure packaging.

All deliveries are done under the international pharmaceutical export compliance regulations.

Why Source With Oddway International.

• Companies:Pharmaceutical exporter that is established on a B2B basis.
• Oncology and Breast Cancer Drugs supply chain experience.
• Advocacy of epirubicin injection wholesale needs.
• Assistance in regulatory documentation.
• Sourcing that is ethical through compliant manufactures.
• Experience in the service of institutions in Africa, Southeast Asia, Middle East, and CIS regions.

Important Notice

Epirubicin injection and epirubicin hydrochloride injection are oncology cytotoxic medicines with a very narrow use, which are strictly for hospitals and institutions. The usage and side effect of epirubicin are all referred to regulatory and pharmacovigilance contexts in institutional contexts.